Actively Recruiting
Multi-contrast Versus Multi-sequence Carotid MRI
Led by Maastricht University Medical Center · Updated on 2024-11-26
40
Participants Needed
1
Research Sites
207 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The objective of this study is to validate 2 multi-contrast sequences, namely the Multi-contrast ATherosclerosis Characterization (MATCH) and Bright-blood and black-blOOd phase SensiTive (BOOST) inversion recovery sequence for the quantification of atherosclerotic plaque components with conventional multi-sequence MRI and histology.
CONDITIONS
Official Title
Multi-contrast Versus Multi-sequence Carotid MRI
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with a carotid plaque 2865 2 mm thick based on ultrasound or CTA
- Age 18 years or older (no maximum age)
- Signed informed consent for study participation
You will not qualify if you...
- Patients with carotid plaque less than or equal to 2 mm in size based on ultrasound or CTA
- Standard contraindications for MRI such as electronic implants (pacemakers), metallic eye fragments, vascular clips, or claustrophobia
- Severe co-morbidity, dementia, or pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Maastricht University Medical Center
Maastricht, Limburg, Netherlands
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here